Solve Shares Guidelines on Interactions with Biopharmaceutical Companies
The interactions between patient advocacy organizations and biopharmaceutical companies are critical, although often complex, and
October 2, 2023
The interactions between patient advocacy organizations and biopharmaceutical companies are critical, although often complex, and
Dear Solve Community, As Vice President of Advocacy and Engagement, I’m excited to share our
Solve Vice President of Advocacy and Engagement Emily Taylor is co-author of “What Long Covid
Dear Solve M.E. Community, With sincere gratitude, I am excited for this privilege to stand,
We are excited to launch our new patient-centered data platform, Solve Together! Solve Together brings
Our flagship research and advocacy journal, The Chronicle, has arrived! This special edition features key
This article by Charlotte Kilpatrick originally appeared on VaccineNation.org. Although the World Vaccine Congress West Coast is
Last month, Senators Tim Kaine (D-VA) and Todd Young (R-IN) introduced the bipartisan Long COVID
On August 8, Severe M.E. Day, we reflect on the tremendous toll this devastating disease
Last month, we shared big appropriations wins for our ME/CFS and Long Covid community members
Solve M.E. and the Long COVID Alliance (co-founded by Solve) are among the dozens of
Congressionally Directed Medical Research Programs (CDMRP) provide funding to support therapeutic research related to medical
